(Reuters) – Metlife Inc (MET.N) said on Thursday it assumes U.S. deaths from COVID-19 will rise to about 200,000 by the end of September, but the disease is having minimal overall impact on underwriting.
“We continue to anticipate modest underwriting impacts from COVID-19 on a combined basis, assuming death rises in the U.S. to approximately 200,000 through the third quarter,” Chief Financial Officer John McCallion said on a conference call with investors. MetLife released earnings on Wednesday.
READ ALSO:
